26 Best Pharma Startups in Germany to Watch in 2025

The Definitive Seedtable Ranking of Pharma Startups in Germany

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 26 start-ups with an aggregate funding of $648.7m. The average funding per company in this subset is $25.0m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

1

Funding Rounds

$15.3m

Money raised

Modag is a Wendelsheim-based company developing molecular diagnostics and treatments for neurodegenerative diseases founded in 2013.

2

Funding Rounds

$51.1m

Money raised

Heidelberg Pharma is a Ladenburg-based pre-clinical drug discovery and development company working on developing anti-cancer and anti-inflammatory drugs.

1

Funding Rounds

$4.6m

Money raised

Cytena is a biotechnology company and developer of a single-cell printing technology designed to assist contact-free deposition of single cells encapsulated in micro-droplets.

1

Funding Rounds

$8.0m

Money raised

AdvanceCOR is a Planegg-based company developing drugs and diagnostics for the treatment of cardiovascular diseases.

2

Funding Rounds

Innoplexus is an AI for Drug Discovery founded in 2015 by Gunjan Bhardwaj.

2

Funding Rounds

$22.3m

Money raised

leon-nanodrugs is a Bayern, Germany-based company that specializes in researching and developing nanotechnology-based drugs.

2

Funding Rounds

$8.6m

Money raised

Developer of a pharmaceutical-based supply-chain management platform intended to help governments and businesses deliver healthcare in the fastest-growing parts of the world. The company's platform helps to digitize, modernize, strengthen, and sustain the supply chains through easy access.

Location:

Key people:

1

Funding Rounds

A pharmaceutical company specializing in drug candidates used for in out-patient and hospital-based sedation

6

Funding Rounds

$101.8m

Money raised

Novaliq is a drug Delivery.

1

Funding Rounds

$32.0m

Money raised

Zava is an european tele-medicine company founded in 2011.

Location:

3

Funding Rounds

$34.9m

Money raised

Small Molecules based on Omega-3 Fatty acid metabolites

3

Funding Rounds

$10.2m

Money raised

Atriva Therapeutics is an inhibitors against respiratory viral infections founded in 2015.

1

Funding Rounds

$74.8m

Money raised

Anti-Infectives

4

Funding Rounds

$38.8m

Money raised

4TEEN4 Pharmaceuticals is an Hennigsdorf-based medical diagnostics company manufacturing biomarkers for organ dysfunction.

3

Funding Rounds

$66.9m

Money raised

Allecra Therapeutics is a multi drug-resistant bacterial infections founded in 2013.

1

Funding Rounds

$2.7m

Money raised

NEUWAY Pharma GmbH is a cns drug delivery platform.

1

Funding Rounds

$7.0m

Money raised

MerLion Pharmaceuticals is a biopharmaceutical company focused on the development of novel antibiotics to combat the evolving threat of bacterial infections in humans and animals.

1

Funding Rounds

$11.3m

Money raised

AI-powered data analytics software provider for biopharma industry.

1

Funding Rounds

$2.5m

Money raised

Provider of a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models.

Location:

Key people:

1

Funding Rounds

$73.8m

Money raised

Eleva is a moss-derived Drug Discovery Platform founded in 1999.

1

Funding Rounds

$2.5m

Money raised

Biovox is a sustainable bioplastics manufacturer for medical applications founded in 2021 by Vinzenz Nienhaus.

Key people:

1

Funding Rounds

$5.5m

Money raised

Algiax Pharmaceuticals is a small Molecule GABAa receptor Modulator.

1

Funding Rounds

$10.0m

Money raised

Apogenix is a protein therapeutics.

1

Funding Rounds

$8.0m

Money raised

Vaximm is developing oral T-cell immunotherapies to treat cancer patients.

1

Funding Rounds

$1.3m

Money raised

1

Funding Rounds

$55.0m

Money raised

InfalRX is a Germany-based company.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.